The output of China’s biological industry is expected to reach 10 trillion yuan (1.5 trillion U.S. dollars) in 2022. The compound annual growth rate of the bio-industry in China has been over 15 percent since 2011, according to a white paper on the industry jointly released by Tianjin Institute of Industrial Biotechnology and Chengdu Library and Information Center, both affiliated with Chinese Academy of Sciences.
Biossance™, the consumer beauty brand from Amyris, Inc., the US integrated renewable products company, announced its planned launch in Sephora’s retail stores where the brand’s expansive line of high-performance skin care products will be available to consumers. The rollout to initial participating stores will begin in February 2017 and coincide with launching on Sephora online. Additional in-store and online marketing activities with Sephora to highlight the Biossance brand shortly following launch are planned.
The Minister of Science and Technology of South Africa, Derek Hanekom, launched the National Bioeconomy Strategy last Tuesday in Pretoria. The science-based Bioeconomy Strategy, approved by South African Cabinet in November last year, positions bio-innovation as essential to the achievement of government’s industrial and social development goals. The strategy calls for industry, science councils, government departments and academia to cooperate closely to ensure that biotechnology and bio-innovations are market relevant and find easier application in South Africa.